• House Speaker Mike Johnson has not committed to a proposal to extend enhanced Affordable Care Act (ACA) subsidies, leaving a key healthcare funding issue unresolved.
  • The enhanced premium tax credits, which make marketplace health plans more affordable for millions, are set to expire at the end of 2025, creating a ticking clock for Congress.
  • The lack of commitment from the Speaker's office casts uncertainty over the future of the subsidies and signals potential hurdles in upcoming budget negotiations.

House Speaker Mike Johnson (R-La.) has not committed to a proposal to extend enhanced Affordable Care Act subsidies, according to people familiar with the matter, leaving a critical piece of healthcare policy in limbo as Congress faces a year-end deadline to address a host of expiring tax provisions.

The enhanced premium tax credits, first expanded under the American Rescue Plan Act and later extended by the Inflation Reduction Act, are scheduled to sunset after 2025. These subsidies have been credited with driving record ACA marketplace enrollment by lowering out-of-pocket costs for middle-income families. Without congressional action, an estimated millions of people could see their premiums spike.

While details of the specific offer presented to the Speaker's office remain unclear, the non-commitment suggests significant political hurdles remain. A spokesperson for Speaker Johnson did not immediately respond to a request for comment on the negotiations. The stance aligns with broader Republican scrutiny of ACA-related spending but puts the party at odds with healthcare industry groups and some insurers who have been lobbying for an extension to provide market stability.

Efforts to attach an extension to must-pass legislation, such as a potential year-end tax package, have reportedly hit a snag without buy-in from House Republican leadership. The dynamic creates a complex negotiation landscape, pitting the desire to avoid premium hikes ahead of an election year against fiscal conservative priorities. Some analysts suggest the issue may be punted into 2025, closer to the actual expiration date, though that would create uncertainty for insurers setting their 2026 rates.

Market reaction has been muted but attentive. Shares of major publicly-traded insurers and hospital operators showed little movement in afternoon trading, though sector analysts note that prolonged uncertainty could pressure valuations for companies with significant ACA marketplace exposure. The Congressional Budget Office has previously estimated that making the enhanced subsidies permanent would carry a significant cost over a decade, a figure that is likely central to the debate.

Correction: An earlier version of this article misstated the year the enhanced subsidies are set to expire. They expire at the end of 2025, not 2024.